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Background: The objective of this study is to determine the presence of early-stage atherosclerosis and
the determinants of those with abnormal intima-media thickness (IMT) without coronary calciﬁcation
assessed by carotid duplex and coronary computed tomography in a relatively healthy population and to
compare the results from the two detection methods.
Materials and methods: Data of 181 asymptomatic participants [mean age 50.8 (35e72) years, 131 males]
regarding baseline characteristics; blood biochemistries; Framingham risk score (FRS); metabolic score
(MS); either carotid intima-media thickness (CIMT) or plaque, or both; and coronary artery calciﬁcation
score (CACS) were obtained. Distributional differences between categorized atherosclerosis groups
deﬁned by various methods were compared using Chi-square test, while uni- and multivariate analyses
were conducted to establish independent risk of atherosclerosis.
Results: For all participants, the mean MS was 1.58 and mean FRS was 5.99. Zero CACS was found in 123
individuals, of whom 75 (61%) had abnormal CIMT or plaque existence. After adjusting the confounders,
both male gender and larger BMI were found to be signiﬁcantly associated with abnormal CIMT or plaque
existence in patients with zero CACS in multivariable regression model.
Conclusion: Carotid duplex may detect subclinical vascular atherosclerosis in more than half of asymp-
tomatic patients without coronary artery calciﬁcation detected by coronary computed tomography.
These ﬁndings have important implications for early-stage atherosclerosis screening and implementa-
tion of primary preventive intervention.
Copyright  2012, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Atherosclerotic cardiovascular disease (CVD) results in more
than 19 million deaths worldwide annually, and coronary artery
disease (CAD) may account for the majority of this toll1,2. Despite
major treatment advances in patients with CAD, there are still
victims suffering from sudden cardiac death who are apparently
healthy without prior clinical symptoms. In this regard, early iden-
tiﬁcation of the “vulnerable” patient population could be clinically
important because sudden death as the initial manifestation wasterest.
vision of Cardiology, Depart-
l, Taipei, Taiwan.
).
iwan Society of Geriatric Emergenobserved in up to 20% of the whole CAD population3 and the prog-
nosis of these survivors was generally poor4e6.
So far, it remains clinically challenging to identify those who
would most beneﬁt from the delivery of primary preventive ther-
apeutics beyond lifestyle modiﬁcations. Conventional cardiovas-
cular risk stratiﬁcation scoring, such as the Framingham risk score
(FRS) and metabolic risk score (NCEP-ATP III score)7,8, is effective in
assigning risk for a large population, although is limited in the
ability to characterize individual risk9e11. Noninvasive screenings
tools, including coronary artery calcium score (CACS) by multi-
detector computed tomography (MDCT) and carotid intima-media
thickness (CIMT) by duplex methods, are both well-described,
effective measures that can be introduced to identify early-stage
atherosclerosis with consensus panels established and recom-
mended as potential additional risk stratiﬁers for CVDs12e14.cy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
C.-H. Chen et al.28Although both CIMT and CACS can detect subclinical athero-
sclerosis, the correlation between these two measures has been
reported to be relatively weak, partly because of their baseline
differences in disease nature and ethnicity, and because coronary
calciﬁcation may actually reﬂect a more advanced stage of vascular
diseases13,15,16. Taken together, for patients with more early-stage
atherosclerosis characterized by increased CIMT or plaque forma-
tion using carotid duplex examination, yet without coronary artery
calciﬁcation, namely “zero CACS”, may still worth earlier thera-
peutic intervention. Therefore, the aim of this studywas to examine
the differences and characters of atherosclerosis deﬁned by carotid
duplex and MDCT methods in a cohort of asymptomatic adults
seeking CVD survey.
2. Materials and methods
We enrolled 181 asymptomatic participants (mean age: 50.8
years; range: 35e72 years) without known CVDs who had at least
one CVD risk (including smoking, hypertension, diabetes,
hyperlipidemia, or family history of premature CVD) from
January 1, 2006 to December 31, 2008. Both MDCT and carotid
duplex were performed as screening tools for identifying
subclinical atherosclerosis. Participants were excluded if they
were noticed to have poorly controlled diabetes (HbA1c > 9.0%)
or severe hypertension (>180 mmHg for systolic or >120 mmHg
for diastolic blood pressure), or were currently undergoing
hemodialysis. All participants had detailed medical and family
history reviewed through structured questionnaire. Baseline
anthropometric data and physical examination records were
collected and analyzed. Biochemical data, including fasting and
postprandial serum glucose, lipid proﬁles, blood urea nitrogen,
and creatinine level, were all obtained by Hitachi 7170 Automatic
Analyzer (Hitachi Corp., Hitachinaka, Ibaraki, Japan). Participants
were further stratiﬁed into low, intermediate, and high FRS withTable 1
Characteristics of baseline demographic data, serum biochemistries and estimated cardi
No coronary calciﬁcation
n¼ 123
Normal IMT Abnormal IMT
or plaque
n¼ 48 n¼ 75
Age (y) 48.5 6.4 49.8 6.7
Sex, male (%) 18 (22.5) 62 (77.5)*
SBP (mmHg) 110 13.1 122.6 14.3*
DBP (mmHg) 70.8 10.5 78.3 9.7*
Waist (cm) 74.7 8.2 85 7.7*
Waistehip ratio 0.83 0.07 0.91 0.06*
BMI (kg/m2) 21.8 2.6 24.9 2.7*
AC sugar (mg/dL) 92.3 9.4 102.4 23.4*
PC sugar (mg/dL) 102.4 18.4 108.6 35.5
Cholesterol (mg/dL) 199 39.1 200.5 37.6
Triglyceride (mg/dL) 103.5 55.7 149.1 75.6*
LDL (mg/dL) 126 37.4 132.3 33.4
HDL (mg/dL) 62.9 13.8 50.9 12.7*
Uric acid (mg/dL) 5 1.4 5.9 1.2*
eGFR (mL/min/1.73 m2) 88 17 85.7 14.3
Metabolic score, mean (median, 25the75th) 0.4 (0, 0e1) 1.9 (2, 1e3)*
Framingham score, mean (median, 25the75th) 2.7 (2, 1e4) 6.1 (5, 2e8)*
Hypertension (%) 7 (14.6) 36 (48)*
Diabetes (%) 6 (12.5) 19 (25.3)
Exercise (yes) (%) 7 (14.6) 9 (12)
Smoking, current (yes) (%) 4 (23.5) 13 (76.5)
*p< 0.05 when compared to normal IMT group.
p: All (no coronary calciﬁcation group) versus All (coronary calciﬁcation group).
Hypertension was deﬁned as SBP 140 mmHg or DBP 90 mmHg; diabetes was deﬁned
AC sugar¼ fasting glucose; BMI¼ body mass index; DBP¼ diastolic blood pressur
IMT¼ intima-media thickness; LDL¼ low-density lipoprotein; PC sugar¼ postprandial gassignment of different metabolic score (MS) categories based on
baseline demographic data, anthropometrics, and biochemical
data17.
2.1. CACS quantiﬁcation
Detection and computation of coronary artery calciﬁcationwere
performed using a dedicated ofﬂine workstation (Aquarius 3D
Workstation, TeraRecon, San Mateo, CA, USA) by an automated,
electron-beam CT method. A coronary calciﬁed lesion was deﬁned
as an area with a density >130 HU and covering at least six pixels
by a CT scout image. The Agaston score method was applied by
multiplying each lesion (area) by aweighted CTattenuation score in
the lesion assessment.
2.2. CIMT measurement
The extracranial carotid arteries were assessed with high-
resolution ultrasound scanners, either Acuson Aspen (Acuson
Aspen, Siemens, Malvern, Pennsylvania) or Logiq 7 (GE Healthcare,
Milwaukee, WI, USA), equipped with a 7.5e10 MHz linear-array
transducer. Carotid images were obtained by a trained and certi-
ﬁed vascular technologist. Ultrasonography evaluations were per-
formed in a room with a comfortable temperature following 5e10
minutes of resting in the supine position. Using a leading edge-
to-leading edge technique, all participants had an IMT measure-
ment at the far wall of the distal 1 cm of each common carotid
artery (CCA), carotid bulb, and proximal 1 cm of each internal
carotid artery (ICA). IMT was deﬁned, according to the Mannheim
consensus criteria, as a double-line pattern visualized by B-mode
imaging on both walls of the carotid arteries in a longitudinal
image. In the evaluation of the presence or absence of carotid
plaques, full extracranial arterial bed was interrogated using both
transverse and longitudinal views. Carotid plaque was deﬁned asovascular risk scores categorized by subclinical atherosclerosis in this study.
All Coronary calciﬁcation All p
n¼ 58
Normal IMT Abnormal IMT
or plaque
n¼ 15 n¼ 43
49.3 6.6 51.7 3.6 54.9 6.6 54.1 6.1 <0.0001
80 (61) 12 (23.5) 39 (76.5) 51 (38.9) 0.001
117.6 15.1 120.9 13 127.7 14.9 126 14.6 0.0006
75.4 10.6 74 6.8 78.4 10.2 77.3 9.6 0.25
81 9.3 82.2 6.5 86.2 7.5 85.2 7.4 0.003
0.88 0.07 0.89 0.04 0.92 0.05 0.91 0.05 0.003
23.7 3 23.3 2.7 24.8 2.5 24.4 2.6 0.13
98.5 19.8 97.4 12.4 105.1 18.3 103.1 17.2 0.13
106.1 30.1 103.6 19.9 131.3 54.4 123.9 49.1 0.004
199.9 38 183.7 29.2 197.3 29 193.7 29.4 0.28
131.2 71.8 113.1 82.9 144.2 77.5 136.1 79.4 0.68
129.8 35.1 121.1 26.5 129.5 30.2 127.2 29.2 0.64
55.7 14.3 50.2 9.2 48.1 13.8 48.7 12.7 0.002
5.5 1.3 5.2 1.4 6 1.3* 5.8 1.4 0.20
86.6 15.4 88.3 11.8 81.7 16.5 83.4 15.5 0.21
1.3 (0, 0e2) 1.6 (1, 0e3) 2.3 (2, 1e3) 2.1 (2.5, 1e4) 0.0004
4.8 (4, 1e8) 5.4 (7, 3e8) 9.1 (8, 5e13)* 8.2 (7.5, 5e11) <0.0001
43 (35) 7 (46.7) 20 (46.5) 27 (46.6) 0.14
25 (20.3) 6 (40) 15 (35) 21 (36.2) 0.02
16 (13) 4 (26.7) 9 (20.9)* 13 (22.4) 0.84
17 (65.4) 2 (22.2) 7 (77.8) 9 (34.6) 0.71
as AC sugar >126 mg/dL, PC sugar >200 mg/dL.
e; eGFR¼ estimated glomerular ﬁltration rate; HDL¼ high-density lipoprotein;
lucose; SBP¼ systolic blood pressure.
Early Detection of Subclinical Atherosclerosis 29the presence of focal wall thickening that is at least 50% greater
than that of the surrounding vessel wall or as a focal region with
CIMT greater than 1.5 mm that protrudes into the lumen that is
distinct from the adjacent boundary. All measurements were
repeated three times, and the mean value was noted.
Based on a previous epidemiologic Taiwanese population study,
an average of right and left common CIMT was used as the repre-
sentative CIMT, as reported previously18. Patients with abnormally
high average CIMT (>0.68 mm) or presence of plaque on CCA, ICA,
external carotid artery, bulb, or bifurcation were deﬁned as having
carotid atherosclerosis.
2.3. Traditional cardiovascular risk scores
Traditional cardiovascular risk scores including MS and FRS
were calculated. MS was presented as the numbers of abnormal
components meeting the National Cholesterol Education Program
(NCEP) Panel III criteria (ATP III), with score 0 representing absence
of any abnormal metabolic items and 5 representing an individual
with all ﬁve abnormal metabolic items. The calculation of FRS was
assessed as previously described19,20.Fig. 1. Various combinations of carotid scan results based on IMT or existence of plaque or
using Chi-square test. (A) Existence of plaque or not; (B) abnormal IMT or not by 0.68 mm cu
ﬁndings; and (D) normal IMT without plaque versus those including abnormal IMT with or w
to categorize successfully abnormal carotid scan results into signiﬁcant distributional differ2.4. Statistical analysis
Continuous data were expressed as mean standard deviation,
and categorical data were expressed as frequency or proportion.
Differences of baseline demographics between groups were tested
by Student t test or ManneWhitney U test, with categorical data
being analyzed by Chi-square or Fisher exact test as appropriate. As
mentioned before, patients with any abnormal carotid ﬁndings,
including existence of plaque or abnormally high mean CIMT
(0.68 mm), were deﬁned as subclinical atherosclerosis by carotid
duplex method18. Patients with detected coronary calcium depo-
sition presented as a CACS larger than zerowere classiﬁed as having
subclinical atherosclerosis, as detected by MDCT. Various combi-
nations of abnormal carotid scan results (by either CIMT or exis-
tence of plaque or not) were further categorized into different
groups and compared with coronary calcium deposition by using
Chi-square test to see whether there remained a signiﬁcant
distribution between these two different modalities in assessing
subclinical atherosclerosis. Uni- andmultivariate logistic regression
models were used to determine the baseline clinical variables,
anthropometrics, or related biochemical data in the prediction ofnot in relation to coronary artery calcium deposition were displayed and compared by
toff; (C) either abnormal IMT or existence of plaque versus those without any abnormal
ithout plaque, respectively. These different combinations of carotid scan results failed
ences in relation to coronary calcium deposition. IMT¼ intima-media thickness.
C.-H. Chen et al.30plaque existence or abnormally high CIMT with individual odds
ratio (OR), signiﬁcance (p), and 95% conﬁdence interval (95% CI)
reported.
STATA 8.2 (Stata Corp., College Station, TX, USA) and SPSS 11.0
(SPSS Inc., Chicago, IL, USA) were used to perform statistical anal-
yses, and the signiﬁcance of p level (a-value) was two sided and set
as 0.05.
3. Results
3.1. Baseline clinical information
Table 1 lists the baseline information, anthropometrics, and
both estimated cardiovascular risk scores based on the presence of
coronary calciﬁcationwith or without subclinical atherosclerosis by
carotid duplex scan in our study. Of 181 patients (mean age:
50.8 6.8 years, female: 28%), 123 (68%) had zero CACS while 58
had coronary calciﬁcation (Fig. 1). For those 123 patients without
obvious coronary calciﬁcation, 75 (61%) had subclinical athero-
sclerosis detected by carotid duplex, while for those with obvious
coronary calciﬁcation, up to 74% (n¼ 43) had carotid anomaly
deﬁned by CIMT thickness or existence of plaque (Fig. 1). Generally,
older age, gender, higher blood pressure, and unfavorable anthro-
pometrics (waist and waistehip ratio) were found in the coronaryFig. 2. Various combinations of carotid scan results based on IMT or existence of plaque or n
or not; (B) abnormal IMT by 0.68 mm cutoff; (C) either abnormal IMT or existence of plaque;
plaque, respectively. For those with either abnormal IMT or existence of plaque (C) and those
scores when compared to the other category in each group. IMT¼ intima-media thickness.calciﬁcation group when compared to those without coronary
calciﬁcation (p< 0.05), regardless of the carotid ﬁndings. Also,
higher postprandial serum sugar and lower high-density lipopro-
tein (HDL) level were noted in those with coronary calciﬁcation
(p< 0.05), together with a higher FRS and MS (mean FRS: 8.2 vs.
4.8, p< 0.0001, and mean MS: 2.1 vs. 1.3, p¼ 0.0004, respectively).
Distributions of various combinations of abnormal carotid scan
results (when categorized individually by CIMT anomaly or the
existence of plaque or not) related to coronary artery calcium
deposition (with or without) were further illustrated in Figs. 1 and
2. In brief, whether the coronary calcium deposition existed or not
did not seem to classify successfully various combinations of
abnormal carotid scan results in binary groups (Fig.1: all Chi-square
result >0.05), and the calcium scores are persistently higher for
patients with low CIMT in the absence of carotid plaque when
compared to those groups with abnormal CIMT and/or presence of
carotid plaque (Fig. 2, groups C and D).
In the group without coronary calciﬁcation, those with
abnormal carotid ﬁndings (n¼ 75) had similarly unfavorable
anthropometrics (waist and waistehip ratio), lipid proﬁles, both
higher estimated cardiovascular risks and higher prevalence of
hypertension, diabetes, and smoking behavior. However, these
differences between normal and abnormal carotid scans were less
signiﬁcant in the group with coronary calciﬁcation.ot in relation to coronary calcium scores were further displayed. (A) Existence of plaque
and (D) normal IMT without plaque and those including abnormal IMT with or without
with abnormal IMT together with plaque (D) have signiﬁcantly larger coronary calcium
Table 2
Data of different IMT measures and the association with coronary calcium deposition.
No coronary calciﬁcation All (mean) Coronary calciﬁcation All (mean) p
n¼ 123 n¼ 58
Normal IMT Abnormal IMT or plaque Normal IMT Abnormal IMT or plaque
n¼ 48 n¼ 75 n¼ 15 n¼ 43
Rt CCA (mm),
mean (50th, 25the75th)
0.65 (0.65, 0.63e0.68) 0.74 (0.74, 0.69e0.78)* 0.70 0.07 0.65 (0.66, 0.62e0.68) 0.76 (0.75, 0.70e0.79)* 0.73 0.08 0.04
Lt CCA (mm),
mean (50th, 25the75th)
0.63 (0.63, 0.62e0.65) 0.73 (0.73, 0.69e0.76)* 0.69 0.07 0.63 (0.61, 0.59e0.67) 0.74 (0.73, 0.69e0.78)* 0.71 0.08 0.08
Rt Bif (mm),
mean (50th, 25the75th)
0.86 (0.85, 0.78e0.95) 0.95 (0.95, 0.87e1.03)* 0.91 0.12 0.90 (0.9, 0.8e0.98) 1.00 (0.98, 0.93e1.06)* 0.97 0.11 0.002
Lt Bif (mm),
mean (50th, 25the75th)
0.87 (0.87, 0.83e0.92) 0.96 (0.94, 0.89e1.04)* 0.93 0.11 0.89 (0.84, 0.78e1.0) 0.99 (0.99, 0.9e1.07)* 0.96 0.12 0.06
Plaque, numbers 0 15 15 0 11 11 0.23
*p <0.05 when compared to normal IMT group.
p: All (no coronary calciﬁcation group) versus All (coronary calciﬁcation group).
Bif¼ bifurcation; CCA¼ common carotid artery; IMT¼ intima-media thickness; Lt¼ left; Rt¼ right.
Early Detection of Subclinical Atherosclerosis 313.2. Carotid ﬁndings associated with coronary calciﬁcation
In Table 2, we have further listed the detailed information of
carotid duplex scan in those with and without coronary calciﬁca-
tion. The mean IMT values between normal and abnormal carotid
scan groups categorized by the existence of coronary calciﬁcation
were also displayed. We observed that several carotid abnormal
characters in terms of higher CIMT thickness (for right CCA and
right bifurcation, p¼ 0.04 and p¼ 0.002, respectively) were
observed in those who developed coronary calciﬁcation when
compared to those who did not. Also, we observed a borderline
increase of IMT at right common and left bifurcation carotid artery
area in those with coronary calciﬁcation when compared to those
without (p¼ 0.08 and p¼ 0.06, respectively). However, the distri-
butional proportion of carotid plaque existence between two
different coronary groups was not different (p¼ 0.23).Table 3
Distribution of abnormal carotid scan results based on different estimated cardiovascula
Estimated cardiovascular risk scores Group 1
Metabolic score (0e5) 0 (normal MS)
All (n¼ 181) n¼ 135
IMT (mm) 0.69 0.07
Plaques (%) 15 (11.4)
Higher IMT and no plaque (%) 60 (45.5)
Plaques or higher IMT (%) 75 (56.8)
Plaques and higher IMT (%) 12 (9.1)
Coronary calcium score¼ 0 (n¼ 123) n¼ 90
IMT (mm) 0.69 0.06
Plaques (%) 9 (9.4)
Higher IMT and no plaque (%) 42 (43.8)
Plaques or higher IMT (%) 51 (53.1)
Plaques and higher IMT (%) 7 (7.3)
Estimated cardiovascular risk scores Group 1
Estimated cardiovascular risk scores Group 1
Framingham risk score (5, 20) Low risk (5)
All (n¼ 181) n¼ 106
IMT (mm) 0.7 0.07
Plaques (%) 16 (10.4)
Higher IMT and no plaque (%) 75 (48.7)
Plaques or higher IMT (%) 91 (59.1)
Plaques and higher IMT (%) 14 (9.1)
Coronary calcium score¼ 0 (n¼ 123) N¼ 81
IMT (mm) 0.69 0.06
Plaques (%) 10 (9.2)
Higher IMT and no plaque (%) 53 (48.6)
Plaques or higher IMT (%) 63 (57.8)
Plaques and higher IMT (%) 8 (7.3)
CACS¼ coronary artery calcium score; IMT¼ intima-media thickness; MS¼metabolic sc3.3. Association between traditional cardiovascular risks and
carotid duplex ﬁndings
Abnormal carotid duplex ﬁndings including existence of plaque
or abnormally high IMT in relation to traditional estimated
cardiovascular risks (MS and FRS) are listed in Table 3. Consistently
higher IMT in the abnormal MS score group (3) compared with
the normal MS group (all p< 0.05) was observed in all participants
as well as in those with coronary calcium score equal to zero. In
addition, abnormal MS was signiﬁcantly associated with higher
proportion of abnormal carotid scan result, regardless of the types
of combination, except for existence of plaques that did not reach
statistical signiﬁcance.
For all participants and those with CACS of zero, interme-
diate- to high-risk population, based on FRS, was associated
with higher IMT and all abnormal carotid scan results, except forr scores from all and those with zero CACS.
Group 2 t Test p for Chi-square
or Fisher exact test3 (abnormal MS)
n¼ 46
0.73 0.07 0.001 d
11 (22.5) d Chi¼ 3.57, p¼ 0.06
32 (65.3) d Chi¼ 5.63, p¼ 0.02
43 (87.8) d Chi¼ 15.07, p< 0.001
11 (22.5) d Chi¼ 5.75, p¼ 0.02
n¼ 33
0.74 0.06 0.0006 d
5 (21.7) d Chi¼ 2.73, p¼ 0.010
17 (73.9) d Chi¼ 6.75, p¼ 0.009
22 (95.7) d Chi¼ 14.15, p< 0.001
5 (21.7) d Chi¼ 4.27, p¼ 0.04
Group 2
Group 2 t Test p for Chi-square
or Fisher exact test
Intermediate to high risk (6e20)
n¼ 75
0.75 0.06 <0.0001 d
10 (37) d chi¼ 13.26, p<0.0001
17 (63) d chi¼ 1.87, p¼ 0.17
27 (100) d chi¼ 16.94, p<0.0001
9 (33.3) d chi¼ 12.17, p<0.0001
N¼ 42
0.78 0.07 <0.0001 d
4 (40) d Chi¼ 8.38, p¼ 0.02
6 (60) d Chi¼ 0.47, p¼ 0.49
10 (100) d Chi¼ 6.88, p¼ 0.009
4 (40) d Chi¼ 10.78, p¼ 0.001
ore.
Table 4
Odds ratio (95% CI and p value) for abnormal carotid IMTor plaque existence for zero
CACS by uni- and multivariate analysis.
Univariate model OR 95% CI p
Existence of plaque or abnormally high IMT without coronary calciﬁcation
Age (y) 1.03 0.98e1.09 0.27
Sex, male (%) 7.95 3.44e18.34 <0.0001
SBP (mmHg) 1.07 1.04e1.11 <0.0001
DBP (mmHg) 1.08 1.04e1.13 <0.0001
BMI (kg/m2) 1.58 1.32e1.91 <0.0001
Waist (cm) 1.17 1.10e1.25 <0.0001
AC sugar (mg/dL) 1.09 1.04e1.15 0.001
PC sugar (mg/dL) 1.01 0.99e1.02 0.29
Cholesterol (mg/dL) 1.00 0.99e1.01 0.83
Triglyceride (mg/dL) 1.01 1.00e1.02 0.001
LDL (mg/dL) 1.00 0.99e1.02 0.34
HDL (mg/dL) 0.93 0.91e0.97 <0.0001
Uric acid (mg/dL) 1.79 1.31e2.45 <0.0001
eGFR (mL/min/1.73 cm2) 0.99 0.97e1.01 0.43
Hypertension (%) 7.75 2.52e23.80 <0.0001
Diabetes (%) 2.75 0.85e8.86 0.09
Exercise_(yes vs. no) 0.95 0.31e2.88 0.93
Smoking (yes vs. no) 2.86 0.76e10.71 0.12
Metabolic score 3.99 2.31e0.69 <0.0001
Framingham score 1.29 1.13e1.47 <0.0001
Existence of plaque or abnormally high IMT without coronary calciﬁcation
Model 1
Age (y) 1.05 0.98e1.11 0.16
Sex 8.44 3.59e19.85 <0.0001
Model 2
Age (y) 1.01 0.95e1.08 0.73
Sex 7.09 2.84e17.70 <0.0001
SBP (mmHg) 1.07 1.03e1.11 0.001
Model 3
Age (y) 1.00 1.00e1.08 0.88
Sex 5.39 2.01e14.45 0.001
SBP (mmHg) 1.04 1.00e1.09 0.04
BMI (kg/m2) 1.39 1.13e1.71 0.002
Model 4
Age (y) 1.00 0.92e1.09 0.97
Sex 4.59 1.29e16.28 0.018
SBP (mmHg) 1.04 0.99e1.08 0.12
BMI (kg/m2) 1.35 1.07e1.72 0.013
Hypertension 1.61 0.47e5.47 0.45
AC sugar (mg/dL) 1.01 0.95e1.07 0.82
Triglyceride (mg/dL) 1.01 0.99e1.02 0.55
Cholesterol (mg/dL) 0.97 0.87e1.09 0.65
HDL (mg/dL) 1.03 0.92e1.16 0.61
LDL (mg/dL) 1.02 0.91e1.15 0.72
Model 1: adjusted for age groups and gender.
Model 2 Model 1 plus systolic BP.
Model 3: Model 2 plus body mass index.
Model 4: Model 3 plus hypertension, fasting glucose, triglyceride, cholesterol, HDL,
and LDL. AC sugar¼ fasting glucose; BMI¼ body mass index; CACS¼ coronary
artery calcium score; DBP¼ diastolic blood pressure; eGFR¼ estimated glomerular
ﬁltration rate; HDL¼ high-density lipoprotein; IMT¼ intima-media thickness;
LDL¼ low-density lipoprotein; PC sugar¼ postprandial glucose; SBP¼ systolic
blood pressure.
C.-H. Chen et al.32the combination of higher IMT without detectable carotid
plaque.
3.4. Determinants of abnormal carotid duplex ﬁndings without
coronary calciﬁcation
Uni- and multivariable models used in identifying the variables
related to abnormal carotid ﬁndings deﬁned as abnormally high
IMT or existence of plaques are listed in Table 4. In the univariate
model, male gender, increased blood pressure, higher body mass
index or waist circumference, higher blood sugar, triglyceride and
uric acid level, hypertension history, and both traditional cardio-
vascular risk factors all contributed signiﬁcantly (p< 0.05) to
increased risk of abnormal IMT or plaque development. In the
different multivariable models, male gender and larger body mass
index remained to be independent risk factors for abnormal carotid
duplex ﬁndings even after adjustment for lipid proﬁles in patients
without coronary artery calcium deposition.
4. Discussion
In this study, we reported the relationship between traditional
cardiovascular risk scores and subclinical atherosclerosis in terms
of both abnormal carotid artery study results and that deﬁned by
coronary artery calciﬁcation. We observed that there exists some
discrepancy while using these different methods in deﬁning the
presence of atherosclerosis. We further explored the clinical
determinants and different clinical manifestations for those with
abnormal carotid duplex study results yet without coronary calci-
ﬁcation deposits.
As previous studies have consistently shown that coronary
calciﬁcation is an independent predictor of carotid artery athe-
rosclerosis21e23, data regarding the extent of possible abnormalities
of carotid arteries without coronary calciﬁcation in asymptomatic
patients remain scarce in Taiwanese population. The principal
ﬁnding in this study is that a substantial percentage of relatively
asymptomatic and healthy individuals free from coronary calciﬁ-
cation may have subclinical atherosclerotic changes, as determined
by ultrasonography study of the carotid arteries. The clinical
signiﬁcance of this ﬁnding is further emphasized by the well-
established rule that atherosclerosis detected by ultrasonography
of the carotid artery is a strong predictor of adverse cardiovascular
events24e27. Similar results had been corroborated by investigators
from Cedars-Sinai Medical Center, who found that 55% of a primary
prevention population without coronary artery calciﬁcation or
diseased thoracic aorta actually had carotid artery plaques as
demonstrated by ultrasonography28.
Although both carotid artery study and coronary artery calcium
deposits may help risk stratiﬁcation, their comparative abilities and
potential diversity as screening tools in identifying early-stage,
subclinical atherosclerosis in different populations remained less
established. From our data, 48 (26.5%) patients who were classiﬁed
as having low-risk carotid duplex study results also had low-risk
CACS, and only 15 (8.29%) patients with low-risk carotid study
results were placed into a higher-risk category because of abnormal
coronary study, whereas 75 (41.4 %) patients with a CACS of zero
had abnormal carotid study, which may indicate an even earlier-
stage atherosclerosis. Furthermore, for those with abnormal
carotid scan results, although having coronary calcium score of
zero, also demonstrated higher cardiovascular risks scores in terms
of either MS or FRS in our study. These ﬁndings further support the
notion that carotid duplex study may be more useful than CACS for
the detection of earlier-stage or subclinical atherosclerosis in
asymptomatic patients. As CACS is helpful in determining whether
or not a patient is at an increased risk of future adverse CVD events,these data may not be particularly clinically precise for asymp-
tomatic patients with a CACS of zero. In this regard, carotid artery
study may serve as a more useful measure of subclinical athero-
sclerosis with a higher negative predictive value in this group.
Owing to the fact that implementation of carotid study results
could be relatively simple and noninvasive for large-scale pop-
ulation studies, in our opinion, it is thus more suitable in clinical
application.
From the viewpoint of preventive medicine, screening for CVD
should not be limited to merely determining probability of a real
diseased group; ideally, it should be able to detect early-stage or
subclinical diseases. The results of this study indicated that carotid
artery duplex could be more useful than CACS in detecting
subclinical atherosclerosis in asymptomatic patients. In this
Early Detection of Subclinical Atherosclerosis 33respect, early identiﬁcation for earlier-stage atherosclerotic status
by carotid artery study with effective therapeutic intervention
provided would probably be most beneﬁcial rather than clinical
judgment by CT method, given the fact that arterial calciﬁcation
may reﬂect as later stage of vascular diseases. More importantly,
growing evidence also showed that its absence does not exclude
the presence of noncalciﬁed “vulnerable” plaque29.
Accumulating data from clinical studies have readily shown that
statins are able to slow the progression or even lead to carotid
atherosclerosis regression by assessing CIMT via B-mode ultra-
sound measurement30e32. Although interventions have not been
shown to be effective in reducing CACS, they have been shown to
slow the progression of CIMT and even to result in partial regres-
sion33. Additionally, aggressive lipid lowering with atorvastatin has
been shown to be more effective in reducing CIMT than conven-
tional lipid-lowering therapy34,35. Therefore, carotid artery duplex
may be a better alternative for monitoring disease progression
during therapeutic interventions.5. Limitations
First, the ﬁndings of this study are based on a relatively small
sample size and are observational. However, large primary
prevention trials involving patients with atherosclerosis as deﬁned
by CIMT will be both costly and lengthy.
Second, the deﬁnitive effect of an intervention was not tested in
our study. However, the ﬁndings of METEOR trial demonstrate that
in relatively same group of middle-aged adults with FRS lower than
10% and evidence of subclinical atherosclerosis, intervention of
rosuvastatin treatment could result in statistically signiﬁcant
reductions in the rate of progression of maximum CIMT during a 2-
year period compared with placebo.
6. Conclusion
Carotid duplex study is able to identify subclinical atheroscle-
rosis in relatively healthy and asymptomatic patients with a CACS
of zero. Even though the existence of abnormal CIMT without
coronary calcium deposition still tracks with unfavorable cardio-
vascular risks by using conventional risk estimators. These ﬁndings
may have important implications for vascular disease screening
and implementation of primary prevention strategies in Taiwanese
population.
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